Skip to Content

Potassium Phosphate Injection

Last Updated: May 11, 2018
Status: Current

Reason for the Shortage
    • American Regent has not had potassium phosphate injection available since 2012. It is unclear if and when product will return to market.
    • Fresenius Kabi had potassium phosphate injection on shortage due to increased demand.
    • Pfizer had potassium phosphate injection on shortage due to manufacturing delays.
Available Products
    • Potassium Phosphate injection, Fresenius Kabi, 3 mmol/mL, 15 mL vial, 25 count, NDC 63323-0086-15
    • Potassium Phosphate injection, Fresenius Kabi, 3 mmol/mL, 5 mL vial, 25 count, NDC 63323-0086-05
    • Potassium Phosphate injection, Fresenius Kabi, 3 mmol/mL, 50 mL vial, 25 count, NDC 63323-0086-50
    • Potassium Phosphate injection, Pfizer, 3 mmol/mL, 15 mL vial, 25 count, NDC 00409-7295-01
    • Glycophos injection, Fresenius Kabi, 1 mmol/mL, 20 mL vial, 10 count, NDC 63323-0241-20

Estimated Resupply Dates

    • All marketed presentations are available.

Safety

    • Pfizer has issued a recall on 7 lots of potassium phosphate 3 mmol/mL 15 mL vials due to sterility concerns. https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm563382.htm

Alternative Agents & Management

    • In cooperation with FDA, Fresenius Kabi USA is providing Glycophos (sodium glycerophosphate) injection to the US market to help alleviate the shortage of phosphate injections. Glycophos is manufactured in an FDA-approved facility in Norway by Fresenius Kabi AG. Details can be found on https://www.fda.gov/downloads/drugs/drugsafety/drugshortages/ucm591758.pdf

Updated

Updated May 11, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 31, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide